million people affected worldwide
Current Treatments
Psychedelic research currently is in Phase Ia
Neurocognitive disorders refer to a decrease in mental function due to something other than psychiatric illness. Dementia, Alzheimer’s and traumatic brain injury are causes of neurocognitive disorders.
Psychedelics are showing promise in restoring neuronal (brain cell) connections. It is hypothesised, but still to be thoroughly researched, that they can help with the psychological outfall and restore brain function.
This topic page is linked to our papers but doesn’t yet have a full explanation.
Traumatic Brain Injury is a subtopic of Neurocognitive Disorders.
Highlighted Institutes
These are the institutes, from companies to universities, who are working on Neurocognitive Disorders.
Highlighted People
These are some of the best-known people, from researchers to entrepreneurs, working on Neurocognitive Disorders.
Linked Research Papers & Trials
Pro & Business members will be able to see all linked papers and trials directly on this topic page.
This information is still available for you by selecting Neurocognitive Disorders on the Papers and Trials pages respectively.
See the information directly on this page with a paid membership.